- Coinbase CEO Brian Armstrong publicly signaled growing crypto-industry interest in longevity science, specifically highlighting Matt Kaeberlein’s rapamycin research as a key study (Peter Attia podcast episode linked).  
- The SecureDNA project announced a search for a Software Development Manager to build global, automated DNA-synthesis screening infrastructure aimed at blocking both “careless and malicious” orders.  
- Channel participants criticized SecureDNA’s approach: concerns over centralized censorship authority, the ease of circumventing filters with exon splicing, and skepticism about defining “careless” use.  
- Discussion noted that current DNA-synthesis volumes remain low enough to permit computationally expensive machine-learning screening, implying the window for effective control may be narrow.